Smolen JS - Search Results

1

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Michaud K, Pope JE, Emery P, Zhu B, Gaich CL, DeLozier AM, Zhang X, Dickson CL, Smolen JS. Michaud K, et al. Among authors: smolen js. Rheumatol Ther. 2019 Sep;6(3):409-419. doi: 10.1007/s40744-019-0164-4. Epub 2019 Jun 21. Rheumatol Ther. 2019. PMID: 31228100 Free PMC article.

2

Issues in rheumatoid arthritis.

Emery P, Smolen J. Emery P, et al. Lancet. 1999 Apr 3;353(9159):1186. doi: 10.1016/S0140-6736(05)74407-X. Lancet. 1999. PMID: 10210007 No abstract available.

3

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P. Maini R, et al. Lancet. 1999 Dec 4;354(9194):1932-9. doi: 10.1016/s0140-6736(99)05246-0. Lancet. 1999. PMID: 10622295 Clinical Trial.

4

Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story.

Smolen JS, Graninger WB, Emery P. Smolen JS, et al. Rheumatology (Oxford). 2000 Jul;39(7):689-92. doi: 10.1093/rheumatology/39.7.689. Rheumatology (Oxford). 2000. PMID: 10908683 No abstract available.

5

Efficacy and safety of leflunomide in active rheumatoid arthritis.

Smolen JS, Emery P. Smolen JS, et al. Rheumatology (Oxford). 2000 Jun;39 Suppl 1:48-56. doi: 10.1093/oxfordjournals.rheumatology.a031495. Rheumatology (Oxford). 2000. PMID: 11001380

6

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Emery P, et al. Among authors: smolen js. Ann Rheum Dis. 2002 Apr;61(4):290-7. doi: 10.1136/ard.61.4.290. Ann Rheum Dis. 2002. PMID: 11874828 Free PMC article. Review.

7

Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study.

Aletaha D, Smolen JS. Aletaha D, et al. Among authors: smolen js. J Rheumatol. 2002 Aug;29(8):1631-8. J Rheumatol. 2002. PMID: 12180721

8

Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.

Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, Smolen JS. Machold KP, et al. Among authors: smolen js. J Rheumatol. 2002 Nov;29(11):2278-87. J Rheumatol. 2002. PMID: 12415582

9

A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P. Smolen JS, et al. Rheumatology (Oxford). 2003 Feb;42(2):244-57. doi: 10.1093/rheumatology/keg072. Rheumatology (Oxford). 2003. PMID: 12595618

10

Infliximab in active early rheumatoid arthritis.

Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, St Clair EW, Weisman M, Smolen J, Lipsky PE, Maini RN. Breedveld FC, et al. Ann Rheum Dis. 2004 Feb;63(2):149-55. doi: 10.1136/ard.2003.013961. Ann Rheum Dis. 2004. PMID: 14722203 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

821 results

Search Page